When is evenity off patent canada?

Evenity (romosozumab-aqqg) is a patented biologic. In Canada, there isn’t a single fixed “off-patent” date you can rely on without checking the patent families and regulatory data protections. The expiry depends on multiple patent families (composition, uses, methods, etc.) and any extensions (for example, certificates of supplementary protection or pediatric extensions, if applicable).

What you can do to get the exact date:
- Look up romosozumab in the Canadian Patent Database (IP Canada) and in WIPO Patentscope to identify the Canadian national phase patents covering romosozumab and their expiry dates.
- Check for any Certificates of Supplementary Protection (CSP) that may extend protection for romosozumab in Canada.
- Be aware that even after patent expiry, regulatory data protection or other market exclusivities can affect when a biosimilar can actually enter the market.

If you’d like, I can guide you step-by-step on how to perform these searches or help interpret the results if you provide links or excerpts from the patent records. Do you want me to walk you through a search strategy or try to locate the current Canadian patent records for romosozumab?